Prognostic and predictive value of a malignancy-risk gene signature in early-stage non-small cell lung cancer.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of the National Cancer Institute

• Publication date

  2011-12-21

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/jnci/djr420PMID 22157961PMCID PMC3243673
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Robust Gene Expression Signature from Formalin-Fixed Paraffin-Embedded Samples Predicts Prognosis of Non–Small-Cell Lung Cancer Patients

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• A novel network model identified a 13-gene lung cancer prognostic signature

  2011cited by this paper
• Hybrid Models Identified a 12-Gene Signature for Lung Cancer Prognosis and Chemoresponse Prediction

  2010cited by this paper
• A breast cancer prognostic signature predicts clinical outcomes in multiple tumor types.

  2010cited by this paper
• Evaluation of malignancy-risk gene signature in breast cancer patients

  2010cited by this paper
• Adoption of adjuvant chemotherapy for non-small-cell lung cancer: a population-based outcomes study.

  2010cited by this paper
• Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer.

  2010influential reference
• Gene profiling of clinical routine biopsies and prediction of survival in non-small cell lung cancer.

  2010cited by this paper
• Identification of Gene Signatures and Molecular Markers for Human Lung Cancer Prognosis using an In vitro Lung Carcinogenesis System

  2009cited by this paper
• Relapse-related molecular signature in lung adenocarcinomas identifies patients with dismal prognosis.

  2009influential reference
• Prognostic gene signatures for non-small-cell lung cancer

  2009cited by this paper
• An Immune Response Enriched 72-Gene Prognostic Profile for Early-Stage Non–Small-Cell Lung Cancer

  2009cited by this paper
• Genomic prognostic models in early-stage lung cancer.

  2009cited by this paper
• Proliferative genes dominate malignancy-risk gene signature in histologically-normal breast tissue

  2009influential reference
• Prognostic factors versus predictive factors: Examples from a clinical trial of erlotinib

  2008cited by this paper
• Proteomic Contributions to Personalized Cancer Care*

  2008cited by this paper
• A Multigene Assay Is Prognostic of Survival in Patients with Early-Stage Lung Adenocarcinoma

  2008cited by this paper
• On the eve of personalized medicine in oncology.

  2008cited by this paper
• Three-Gene Expression Signature Predicts Survival in Early-Stage Squamous Cell Carcinoma of the Lung

  2008cited by this paper
• Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study

  2008influential reference
• Non-overlapping and non-cell-type-specific gene expression signatures predict lung cancer survival.

  2008cited by this paper
• Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.

  2008cited by this paper
• Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group.

  2008cited by this paper
• A five-gene signature and clinical outcome in non-small-cell lung cancer.

  2007cited by this paper
• Cancer Care Ontario and American Society of Clinical Oncology Adjuvant Chemotherapy and Adjuvant Radiation Therapy for Stages I-IIIA Resectable Non-Small-Cell Lung Cancer Guideline.

  2007cited by this paper
• Changing trends in the distribution of the histologic types of lung cancer: a review of 4,439 cases.

  2007cited by this paper
• Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline.

  2007cited by this paper
• The prognostic role of a gene signature from tumorigenic breast-cancer cells.

  2007cited by this paper
• Gene Expression Signature Predicts Recurrence in Lung Adenocarcinoma

  2007cited by this paper
• Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial.

  2006cited by this paper
• Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung.

  2006cited by this paper
• Common markers of proliferation

  2006cited by this paper
• Oncogenic pathway signatures in human cancers as a guide to targeted therapies

  2006cited by this paper
• Genes that mediate breast cancer metastasis to lung

  2005cited by this paper
• Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer.

  2005cited by this paper
• Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer.

  2004cited by this paper
• Summaries of Affymetrix GeneChip probe level data.

  2003cited by this paper
• The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma.

  2003cited by this paper
• Molecular profiling of non-small cell lung cancer and correlation with disease-free survival.

  2002cited by this paper
• Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation.

  2002cited by this paper
• Molecular portraits and the family tree of cancer

  2002cited by this paper
• Controlling the false discovery rate: a practical and powerful approach to multiple testing

  1995cited by this paper
• Proportional hazards tests and diagnostics based on weighted residuals

  1994cited by this paper

• An Open, Harmonized Genomic Meta-Database Enabling AI-Based Personalization of Adjuvant Chemotherapy in Early-Stage Non-Small Cell Lung Cancer

  2025cites this paper
• A novel prognostic signature based on smoking-associated genes for predicting prognosis and immune microenvironment in NSCLC smokers

  2024cites this paper
• Enhanced Efficiency in Lung Cancer Classification via Deep Learning Ensembles

  2024cites this paper
• Intelligent prognosis evaluation system for stage I-III resected non-small-cell lung cancer patients on CT images: a multi-center study

  2023cites this paper
• Assessment of Pediatric Cancer and Its Relationship to Environmental Contaminants: An Ecological Study in Idaho

  2022cites this paper
• A Six-Gene Prognostic and Predictive Radiotherapy-Based Signature for Early and Locally Advanced Stages in Non-Small-Cell Lung Cancer

  2022cites this paper
• Benefits from Adjuvant Chemotherapy in Patients with Resected Non-Small Cell Lung Cancer: Possibility of Stratification by Gene Amplification of ACTN4 According to Evaluation of Metastatic Ability

  2022cites this paper
• Phenotypic profiling of pancreatic ductal adenocarcinoma plasma-derived small extracellular vesicles for cancer diagnosis and cancer stage prediction: a proof-of-concept study.

  2022cites this paper
• Molecular Radiobiology in Non-Small Cell Lung Cancer: Prognostic and Predictive Response Factors

  2022cites this paper
• Identification of Master Regulators Driving Disease Progression, Relapse, and Drug Resistance in Lung Adenocarcinoma

  2022cites this paper
• Artificial Intelligence in Bulk and Single-Cell RNA-Sequencing Data to Foster Precision Oncology

  2021cites this paper
• Comprehensive Transcriptomic Analysis Reveals Prognostic Value of an EMT-Related Gene Signature in Colorectal Cancer

  2021cites this paper
• Predictive markers based on transcriptome modules for vinorelbine-based adjuvant chemotherapy for lung adenocarcinoma patients.

  2021cites this paper
• Utilization of target lesion heterogeneity for treatment efficacy assessment in late stage lung cancer

  2021cites this paper
• Molecular Analysis of ZNF71 KRAB in Non-Small-Cell Lung Cancer

  2021cites this paper
• RB/E2F1 as a master regulator of cancer cell metabolism in advanced disease.

  2021cites this paper
• Immunoscore Predicts Survival in Early-Stage Lung Adenocarcinoma Patients

  2020cites this paper
• On evaluating how well a biomarker can predict treatment response with survival data

  2020cites this paper
• Unique metastasis‐associated lncRNA signature optimizes prediction of tumor relapse in lung adenocarcinoma

  2020cites this paper
• Immunohistochemical validation study of 15-gene biomarker panel predictive of benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of JBR.10

  2020cites this paper
• Gene selection of non-small cell lung cancer data for adjuvant chemotherapy decision using cell separation algorithm

  2020cites this paper
• Biomarkers in Early Diagnosis and Early Stage Lung Cancer: The Clinician’s Point of View

  2020cites this paper
• Development of Malignancy-Risk Gene Signature Assay for Predicting Breast Cancer Risk.

  2020cites this paper
• Development and Validation of an Autophagy Score Signature for the Prediction of Post-operative Survival in Colorectal Cancer

  2019cites this paper
• TMEM213 as a novel prognostic and predictive biomarker for patients with lung adenocarcinoma after curative resection: a study based on bioinformatics analysis.

  2019cites this paper
• Helicase lymphoid-specifics and selenoprotein P1 are potential candidate genes in the progression and prognosis of lung adenocarcinoma

  2019cites this paper
• Novel Genomic-Based Strategies to Personalize Lymph Node Radiation Therapy.

  2019cites this paper
• Risk stratification for lung adenocarcinoma on EGFR and TP53 mutation status, chemotherapy, and PD‐L1 immunotherapy

  2019cites this paper
• Subgroup Identification for Time-to-event Data Based on AFT Model

  2019cites this paper
• Identification of prognostic genes in colorectal cancer through transcription profiling of multi-stage carcinogenesis.

  2018cites this paper
• A robust gene signature for the prediction of early relapse in stage I–III colon cancer

  2018cites this paper
• Development of predictive signatures for treatment selection in precision medicine with survival outcomes

  2018cites this paper
• Molecular prediction of adjuvant cisplatin efficacy in Non-Small Cell Lung Cancer (NSCLC)—validation in two independent cohorts

  2018cites this paper
• A multi-layered incremental feature selection algorithm for adjuvant chemotherapy effectiveness/futileness assessment in non-small cell lung cancer

  2017cites this paper
• Linc-ing Circulating Long Non-coding RNAs to the Diagnosis and Malignant Prediction of Intraductal Papillary Mucinous Neoplasms of the Pancreas

  2017cites this paper
• Prognostic and predictive biomarkers post curative intent therapy.

  2017cites this paper
• Nomogram integrating gene expression signatures with clinicopathological features to predict survival in operable NSCLC: a pooled analysis of 2164 patients

  2017cites this paper
• An individualized gene expression signature for prediction of lung adenocarcinoma metastases

  2017cites this paper
• Comprehensive evaluation of published gene expression prognostic signatures for biomarker-based lung cancer clinical studies

  2017cites this paper
• Gene Expression Signatures of the Tumor Microenvironment: Relation to Tumor Progress in Breast Cancer

  2017cites this paper
• Beyond PD-L1 testing-emerging biomarkers for immunotherapy in non-small cell lung cancer.

  2017cites this paper
• Statistical inferences based on outliers for gene expression analysis

  2017cites this paper
• Strategies for power calculations in predictive biomarker studies in survival data

  2016cites this paper
• Early2 factor (E2F) deregulation is a prognostic and predictive biomarker in lung adenocarcinoma

  2016cites this paper
• A Sensitive NanoString‐Based Assay to Score STK11 (LKB1) Pathway Disruption in Lung Adenocarcinoma

  2016cites this paper
• A network-based method for identifying prognostic gene modules in lung squamous carcinoma

  2016cites this paper
• An individualised signature for predicting response with concordant survival benefit for lung adenocarcinoma patients receiving platinum-based chemotherapy

  2016influential citation
• Impacts of Predictive Genomic Classifier Performance on Subpopulation-Specific Treatment Effects Assessment

  2016cites this paper
• Ensemble survival trees for identifying subpopulations in personalized medicine

  2016cites this paper
• Risk factors assessment and risk prediction models in lung cancer screening candidates.

  2016cites this paper
• An 8-gene signature for prediction of prognosis and chemoresponse in non-small cell lung cancer

  2016cites this paper
• Cost-Utility of a Prognostic Test Guiding Adjuvant Chemotherapy Decisions in Early-Stage Non-Small Cell Lung Cancer.

  2016cites this paper
• Genomic biomarkers of recurrence in stage I non-small cell lung cancer

  2015cites this paper
• One-step extrapolation of the prediction performance of a gene signature derived from a small study

  2015cites this paper
• Differential association of STK11 and TP53 with KRAS mutation-associated gene expression, proliferation and immune surveillance in lung adenocarcinoma

  2015cites this paper
• Hybrid Mixture Model for Subpopulation Identification

  2015influential citation
• Plasma MicroRNAs as Novel Biomarkers for Patients with Intraductal Papillary Mucinous Neoplasms of the Pancreas

  2015cites this paper
• Gene Expression Profiling for Early-stage NSCLC

  2015cites this paper
• Subgroup identification for treatment selection in biomarker adaptive design

  2015cites this paper
• Intrinsic cancer subtypes-next steps into personalized medicine

  2015cites this paper
• Improving the Care of Patients With Stage IB Non-Small-Cell Lung Cancer: Role of Prognostic Signatures and Use of Cell Cycle Progression Biomarkers.

  2015cites this paper
• Cancer adjuvant chemotherapy strategic classification by artificial neural network with gene expression data: An example for non-small cell lung cancer

  2015cites this paper
• Prognostic signature of early lung adenocarcinoma based on the expression of ribonucleic acid metabolism-related genes.

  2015cites this paper
• Prognostic Fifteen-Gene Signature for Early Stage Pancreatic Ductal Adenocarcinoma

  2015cites this paper
• Biomarkers for efficacy of adjuvant chemotherapy following complete resection in NSCLC stages I–IIIA

  2015cites this paper
• The total scale for prognosis of survival patients with early stages of non-small cell lung cancer

  2014cites this paper
• MiRNA expression profile reveals a prognostic signature for esophageal squamous cell carcinoma.

  2014cites this paper
• The Expression of Four Genes as a Prognostic Classifier for Stage I Lung Adenocarcinoma in 12 Independent Cohorts

  2014cites this paper
• A Composite Model for Subgroup Identification and Prediction via Bicluster Analysis

  2014cites this paper
• Prognostic impact of alternative splicing-derived hMENA isoforms in resected, node-negative, non-small-cell lung cancer

  2014cites this paper
• Identification of Gene Expression Biomarkers for Predicting Radiation Exposure

  2014cites this paper
• Prognostic markers in lung cancer: is it ready for prime time?

  2014cites this paper
• Collaborative network of predictive markers complicates formation of prognostic groups in patients with advanced lung cancer.

  2014cites this paper
• Senescence-associated-gene signature identifies genes linked to age, prognosis, and progression of human gliomas.

  2014cites this paper
• Sparse principal component analysis in cancer research.

  2014cites this paper
• Usage of Cox-Regression Model for Forecasting of Survival Rate in Patients with the Early Stage of Non-Small Cell Lung Cancer

  2014cites this paper
• Novel Therapeutic Strategies in Lung Cancer

  2014cites this paper
• Biomarker adaptive designs in clinical trials

  2014cites this paper
• TNM classification and clinicopathological factors: what is helpful for adjuvant chemotherapy decision after lung cancer resection?

  2014cites this paper
• Lung Cancer Gene Signatures and Clinical Perspectives

  2013cites this paper
• Genomic Pathology of Lung Cancer

  2013cites this paper
• Molecular classification of non-small-cell lung cancer: diagnosis, individualized treatment, and prognosis

  2013influential citation
• Oncologie thoracique : revue annuelle Thoracic oncology : annual review

  2013cites this paper
• Contribution of the integrative pathology to the discovery of biomarkers for non-small cell lung cancer : integrative pathology and lung cancer

  2013cites this paper
• Endometrial carcinoma: a step closer to individualized therapy? Exploring transcriptional alterations in relation to prognostic biomarkers

  2013cites this paper
• Genetic susceptibility to lung cancer--light at the end of the tunnel?

  2013cites this paper
• A 12-Gene Set Predicts Survival Benefits from Adjuvant Chemotherapy in Non–Small Cell Lung Cancer Patients

  2013cites this paper
• Pharmacogenomic biomarkers for personalized medicine.

  2013cites this paper
• Predictive biomarkers in patients with resected non-small cell lung cancer treated with perioperative chemotherapy

  2013cites this paper
• Lung tumor NF-κB signaling promotes T cell-mediated immune surveillance.

  2013cites this paper
• Forecasting of Survival Rate in Patients with the Early Stage of Non Small Cell Lung Cancer

  2013cites this paper
• Update on recent prognostic markers in adenocarcinoma

  2013cites this paper
• Prognostic and predictive biomarkers in early stage non-small cell lung cancer: tumor based approaches including gene signatures.

  2013cites this paper
• Genetic profiling to predict recurrence of early cervical cancer.

  2013cites this paper
• Biomarkers and molecular testing for early detection, diagnosis, and therapeutic prediction of lung cancer.

  2013cites this paper
• Identification of reproducible gene expression signatures in lung adenocarcinoma

  2013cites this paper
• Identification of Transcriptional Subgroups in EGFR-Mutated and EGFR/KRAS Wild-Type Lung Adenocarcinoma Reveals Gene Signatures Associated with Patient Outcome

  2013cites this paper
• Impacts of Predictive Genomic Classifier Performance on Subpopulation-Specific Treatment Effects Assessment

  2013cites this paper
• The evolving role of the pathologist in the management of lung cancer.

  2012cites this paper
• An alternative view on the task of prognosis.

  2012cites this paper